‘Antipsychotics Increase Mortality in Elderly Patients with Dementia’. N.p., n.d. Web. <http://www.npc.nhs.uk/merec/cns/dementia/merec_extra_no39.php>.
‘Aricept Tablets - Summary of Product Characteristics (SPC) - (eMC)’. N.p., n.d. Web. <http://www.medicines.org.uk/emc/medicine/577/SPC/Aricept>.
Bhasin, Mani et al. ‘Cholinesterase Inhibitors in Dementia with Lewy Bodies—a Comparative Analysis’. International Journal of Geriatric Psychiatry 22.9 (2007): 890–895. Web.
‘British National Formulary’. N.p., n.d. Web. <http://www.bnf.org/bnf/index.htm>.
‘Centre for Medicines Optimisation - MTRAC | Independent Medicines Review | Midlands Therapeutics Review & Advisory Committee | Centre for Medicines Optimisation | Keele University’. N.p., n.d. Web. <http://centreformedicinesoptimisation.co.uk/mtrac/>.
‘Chronic Obstructive Pulmonary Disease’. N.p., n.d. Web. <http://cks.nice.org.uk/chronic-obstructive-pulmonary-disease>.
‘Clinical Guidelines, CG42 - Issued: November 2006’. N.p., n.d. Web. <http://guidance.nice.org.uk/CG42>.
‘Coeliac Disease: Recognition, Assessment and Management | Guidance and Guidelines | NICE’. n. pag. Web. <https://www.nice.org.uk/guidance/ng20>.
‘Commissioners and Healthcare Professionals - Training Videos’. N.p., n.d. Web. <http://healthcheck.nhs.uk/commissioners_and_providers/training/training_videos1/>.
‘Complete Guide to Behavioural and Psychological Symptoms of Dementia’. N.p., n.d. Web. <http://www.ipa-online.org/>.
‘CPPE - Centre for Pharmacy Postgraduate Education’. N.p., n.d. Web. <https://www.cppe.ac.uk/>.
‘DH Living Well with Dementia: A National Dementia Strategy’. N.p., n.d. Web. <https://www.gov.uk/government/organisations/department-of-health>.
‘Ebixa 5mg/Pump Actuation Oral Solution, 20mg and 10 Mg Tablets and Treatment Initiation Pack - Summary of Product Characteristics (SPC) - (eMC)’. N.p., n.d. Web. <http://www.medicines.org.uk/EMC/medicine/10175/SPC/rEbxia+5mg+pump+oral+solution%252c+20mg+and+10+mg+tablets+and+Treatment+Initiation+Pack/>.
‘Electronic Medicines Compendium (eMC)’. N.p., n.d. Web. <http://www.medicines.org.uk/emc/>.
‘---’. N.p., n.d. Web. <http://www.medicines.org.uk/emc/>.
‘---’. N.p., n.d. Web. <https://www.medicines.org.uk/emc/>.
‘Evidence Search - Search Engine for Evidence in Health and Social Care’. N.p., n.d. Web. <https://www.evidence.nhs.uk/>.
‘---’. N.p., n.d. Web. <https://www.evidence.nhs.uk/>.
‘---’. N.p., n.d. Web. <https://www.evidence.nhs.uk/>.
‘Exelon - Summary of Product Characteristics (SPC) - (eMC)’. N.p., n.d. Web. <https://www.medicines.org.uk/emc/search?q=Exelon+>.
‘GOV.UK’. N.p., n.d. Web. <https://www.gov.uk/government/organisations/department-of-health>.
Greene, Russell J., and Norman D. Harris. Pathology and Therapeutics for Pharmacists: A Basis for Clinical Pharmacy Practice. 3rd ed. London: Pharmaceutical Press, 2008. Print.
‘Heart Failure - Chronic’. N.p., n.d. Web. <http://cks.nice.org.uk/heart-failure-chronic>.
Hubley, John, June Copeman, and James Woodall. Practical Health Promotion. 2nd ed. Cambridge: Polity Press, 2013. Print.
Kavirajan, Harish, and Lon S Schneider. ‘Efficacy and Adverse Effects of Cholinesterase Inhibitors and Memantine in Vascular Dementia: A Meta-Analysis of Randomised Controlled Trials’. The Lancet Neurology 6.9 (2007): 782–792. Web.
Kumar, Parveen J., and Michael L. Clark. Kumar & Clark’s Clinical Medicine. 8th ed. Edinburgh: Saunders Elsevier, 2012. Web. <https://www.dawsonera.com/abstract/9780702053047>.
Laverack, Glenn. Health Promotion Practice: Building Empowered Communities. Maidenhead: Open University Press, 2007. Web. <https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=nlebk&AN=234222&site=ehost-live&scope=site&custid=s8454451>.
Macdowall, Wendy, Chris Bonell, and Maggie Davies. Health Promotion Practice. Understanding public health. Maidenhead: Open University Press, 2006. Print.
Maher, Alicia Ruelaz et al. ‘Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults’. JAMA 306.12 (2011): n. pag. Web.
---. ‘Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in AdultsA Systematic Review and Meta-Analysis’. JAMA: The Journal of the American Medical Association 306.12 (2011): n. pag. Web.
‘Map of Medicine | Home’. N.p., n.d. Web. <http://www.mapofmedicine.com/>.
Martinón-Torres, Georgina, Mario Fioravanti, and John Grimley Evans. ‘Trazodone for Agitation in Dementia’. Cochrane Database of Systematic Reviews (2004): n. pag. Web.
‘Medicines Information - Evidence Search - Search Engine for Evidence in Health and Social Care’. N.p., n.d. Web. <https://www.evidence.nhs.uk/>.
‘Medicines Use Review and Prescription Intervention Service’. Web. <http://psnc.org.uk/wp-content/uploads/2013/06/MUR-service-spec-Aug-2013-changes_FINAL.pdf>.
Miller, William R., and Stephen Rollnick. Motivational Interviewing: Helping People Change. 3rd ed. Applications of motivational interviewing. New York: Guilford Press, 2013. Print.
‘National Institute for Health and Care Excellence’. N.p., n.d. Web. <http://www.nice.org.uk/>.
‘NHS Health Check - NHS Choices’. N.p., n.d. Web. <http://www.nhs.uk/Conditions/nhs-health-check/Pages/NHS-Health-Check.aspx>.
‘NICE Clinical Knowledge Summaries (CKS)’. N.p., n.d. Web. <http://cks.nice.org.uk/>.
‘NPC | National Prescribing Centre’. N.p., n.d. Web. <https://www.guidelinesinpractice.co.uk>.
‘---’. N.p., n.d. Web. <https://www.guidelinesinpractice.co.uk>.
‘Optimising Treatment and Care for Behavioural and Psychological Symptoms of Dementia: A Best Practice Guide’. N.p., n.d. Web. <https://www.alzheimers.org.uk/bpsdguide>.
Pierre N. Tariot, M.D.; Rosemary Erb, R.N., B.S.N.; Carol Ann Podgorski, Ph.D.; Christopher Cox, Ph.D.; Shirish Patel, M.D.; Laura Jakimovich, M.S., R.N.; Carrie Irvine, B.A. ‘Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia’. PsychiatryOnline | American Journal of Psychiatry | Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia 155.1 (1998): 54–61. Web.
Prochaska, James O., John C. Norcross, and Carlo C. DiClemente. Changing for Good. New York: William Morrow, 1994. Print.
‘Reminyl Tablets - Summary of Product Characteristics (SPC) - (eMC)’. N.p., n.d. Print.
‘Risperdal Tablets, Liquid & Quicklet - Summary of Product Characteristics (SPC) - (eMC)’. N.p., n.d. Web. <http://www.medicines.org.uk/emc/document.aspx?documentid=12818&docType=SPC>.
Rollnick, Stephen, Pip Mason, and Christopher Butler. Health Behavior Change: A Guide for Practitioners. Edinburgh: Churchill Livingstone, 1999. Print.
Rollnick, Stephen, William R. Miller, and Christopher Butler. Motivational Interviewing in Health Care: Helping Patients Change Behavior. Applications of motivational interviewing. New York: Guilford Press, 2008. Print.
‘Royal Pharmaceutical Society (RPS)’. N.p., n.d. Web. <http://www.rpharms.com/home/home.asp>.
‘Scottish Intercollegiate Guidelines Network (SIGN)’. N.p., n.d. Web. <http://www.sign.ac.uk/>.
‘Service Specification - New Medicine Service (NMS)’. Web. <http://psnc.org.uk/wp-content/uploads/2013/06/NMS-service-spec-Aug-2013-changes_FINAL.pdf>.
Sube Banerjee. ‘The Use of Antipsychotic Medication for People with Dementia: Time for Action. A Report for the Minister of State for Care Services’. 12AD. Web. <http://psychrights.org/research/digest/nlps/BanerjeeReportOnGeriatricNeurolepticUse.pdf>.
‘TA217 Alzheimer’s Disease - Donepezil, Galantamine, Rivastigmine and Memantine: Guidance (MS Word Format)’. N.p., n.d. Web. <http://guidance.nice.org.uk/TA217/Guidance/doc/English>.
‘Treatment Protocol by NHS Medway: Treatment of Behaviour That Challenges’. N.p., n.d. Web. <http://www.kmpt.nhs.uk/policies>.
Waldemar, Gunhild et al. ‘Tolerability of Switching from Donepezil to Memantine Treatment in Patients with Moderate to Severe Alzheimer’s Disease’. International Journal of Geriatric Psychiatry 23.9 (2008): 979–981. Web.
Walker, Roger, and Cate Whittlesea. Clinical Pharmacy and Therapeutics. 5th ed. Edinburgh: Churchill Livingstone, 2012. Web. <https://www.vlebooks.com/Product/Index/173020?page=0&startBookmarkId=-1>.
Warner, James, and Tom Smith. ‘The Rise and Fall of Antipsychotic Prescribing in Dementia. Where Do We Go from Here?’ The rise and fall of antipsychotic prescribing in dementia 14.2 24–27. Print.
